ECOR stock forecast
Our latest prediction for electroCore, Inc.'s stock price was made on the June 7, 2019 when the stock price was at 2.24$.
In the short term (2weeks), ECOR's stock price should outperform the market by 7.28%. During that period the price should oscillate between -10.22% and +27.17%.
In the medium term (3months), ECOR's stock price should outperform the market by 10.57%. During that period the price should oscillate between -21.49% and +53.02%.Get email alerts
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -1.64$ per share.
The book value per share is 2.71$
Three months stock forecastJune 7, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|